Category: Prescription Drugs
North America Prescription Drugs
-
Sleeping Aids
... at a CAGR of 5.3% over the analysis period 2023-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$36.9 Billion by the end ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Pharmacy Market in Us 2024-2028
... market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Animal Health Market In North America 2024-2028
... report on the animal health market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices and Pharmaceuticals), Pain Type, Drug Class, Indication, Distribution Channel and Company Analysis 2024-2032
... Therapeutics Market will reach US$ 36.15 billion by 2032, up from US$ 26.18 billion in 2023, with a CAGR of 3.65% between 2024 and 2032. Many factors are driving the market's rapid expansion such as ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
US Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), Forecasts 2022-2032
... 2023 and is anticipated to grow with a healthy growth rate of more than 7.11% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurring in young children under five years old, originating in ... Read More
-
Addiction Treatment Market, By Type (Alcohol Addiction, Tobacco/Nicotine Addiction, Opioid Addiction, and Others), By Drug Type (Opioids (Buprenorphine, Methadone, Naltrexone), Nicotine Replacement Therapies (Nicotine Gums, Nicotine Patches, Nicotine Lozenges, Non-Nicotine Medication, Varenicline, and Bupropion), By Distribution Channel (Hospital Pharmacies, Medical Stores, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Distribution Channel (Hospital Pharmacies, Medical Stores, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Addiction is a chronic health condition that affects millions globally. It impacts individuals physically ... Read More
-
North America & Europe Epilepsy Market Research Report Information Forecast to 2032 Based on Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, Canada, Europe).
... (US, Canada, Europe) It is projected that the epilepsy market in North America and Europe would increase at a strong rate throughout the study period, with a compound annual growth rate of 8.18%. Recurrent seizures ... Read More
-
North America Cold Sore Treatment (for HSV 1 Virus) Market
... growing at the CAGR of 7.2% in the forecast period of 2024 to 2031. Market Segmentation North America Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, ... Read More
-
North America Pharmacy Automation Market Research Report-Forecast till 2032
... streamline and optimize the workflow in pharmacies, enhancing efficiency, accuracy, and overall patient care. Increasing incidences of chronic diseases and increasing investment to bring technologically based solution in the region are the major factors driving ... Read More
-
Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 424210
... Within Its Industry, and Revenue Forecasts to 2030, NAIC 424210 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals and Druggists' Merchandise ... Read More
-
The Telehealth Weight Loss Market
... their physicians via Zoom video calls and by phone, email and chat. The number of telehealth companies exploded. Then, in 2021-2023, as demand for the GLP-1 weight loss medications took off, many of these telehealth ... Read More
-
U.S. Pet Medication Market - Focused Insights 2024-2029
... in pet ownership drives the U.S. pet medication market. There has been a notable increase in households worldwide and the U.S. that include pets as part of the family. This trend can be attributed to ... Read More
-
North America Ophthalmic Drugs Market 2023-2030
... and the United States are analyzed in this report. The United States is witnessing steady growth in the ophthalmic drugs market. An increasing prevalence of eye diseases, advancements in the technology of drug delivery, investments ... Read More
-
Intravenous Solutions Market, by Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringers, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), by Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, ... Read More
-
Urinary Tract Infection Therapeutic Market, By Drug (Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, and Other Drugs), By Indication (Complicated UTI, Uncomplicated UTI, and Other Indications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 A urinary tract infection (UTI) is an infection in any part of the urinary system. Women are at ... Read More
-
US Hemorrhoid Treatment Market Research Report Forecast to 2032
... the rectal or anal area. Treatment can include lifestyle modifications, over-the-counter remedies, minimally invasive procedures, or surgery, depending on the severity of the condition. The goal is to reduce pain, bleeding, itching, and inflammation while ... Read More
-
U.S. Pharmacy Benefit Management (PBM) Market - Focused Insights 2024-2029
... from 2023-2029. MARKET TRENDS Specialty drugs Continuing to Drive Rx Spend: Specialty drugs represent the fastest-growing area of pharmacy spend. Over the years, specialty drug growth has been driven by adopting innovative drugs, such as ... Read More
-
Pharmaceutical Market in Canada 2024-2028
... market in Canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
U.S. Healthcare Discount Plan Market Share, Size, Trends, Industry Analysis Report, By Service (Dental Care, Hearing Aids, Vision Care, Chiropractic Care, Nurse Services, Virtual Visits, Health Advocate, Prescription Drug, Alternative Medicines, and Others); By Application; Segment Forecast, 2024 - 2032
... Segment Forecast, 2024 - 2032 The U.S. healthcare discount plan market size is expected to reach USD 4.57 billion by 2032, according to a new study by Polaris Market Research. The report “U.S. Healthcare Discount ... Read More
-
The U.S. Weight Loss Market: 2024 Status Report & Forecast
... for 2024. The value of the total market is estimated to have grown to a historic peak of $90 billion in 2023, boosted by soaring sales of the popular prescription GLP-1 weight loss drugs. This ... Read More
-
Rx/Reimbursement Adult Incontinence in the US
... growth in the Rx/reimbursement adult incontinence market in 2023. Euromonitor International's Rx/Reimbursement adult incontinence in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides ... Read More
-
Global Antibiotic Resistance Market, By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Others), By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The ... Read More
Research Assistance
